Calumet Specialty Products Partners (NASDAQ:CLMT) Downgraded by StockNews.com to “Sell”

StockNews.com downgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday. Several other research analysts also recently issued reports on CLMT. HC Wainwright reaffirmed a buy rating and set a $25.00 price objective on shares of Calumet […]

Leave a Reply

Your email address will not be published.

Previous post Stryker (NYSE:SYK) Rating Increased to Buy at StockNews.com
Next post StockNews.com Lowers GlycoMimetics (NASDAQ:GLYC) to Sell